26
Vol. 66, No. 2 2015
Northeast Florida Medicine
Pediatric Oncology
18. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clif-
ford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison
DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM.
Molecular subgroups of medulloblastoma: the current consensus.
Acta Neuropathol.
2012;123(4):465-72.
19. Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson
SJ, Wilson MW, Lustig RH, Kun LE. Craniopharyngioma: the
St. Jude Children’s Research Hospital experience 1984-2001.
Int J
Radiat Oncol Biol Phys.
2002;53(3):533-42.
20. Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott
RM, Tarbell NJ. 20-year experience in childhood craniopharyngio-
ma.
Int J Radiat Oncol Biol Phys.
1993;27(2):189-95.
21. Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy
SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova
LC, Marcus KJ. Long-term clinical outcomes following treat-
ment of childhood craniopharyngioma.
Pediatr Blood Cancer.
2011;56(7):1120-6.
22. Winkfield KM, Linsenmeier C, Yock TI, Grant PE, Yeap BY, Butler
WE, Tarbell NJ. Surveillance of craniopharyngioma cyst growth in
children treated with proton radiotherapy.
Int J Radiat Oncol Biol
Phys.
2009;73(3):716-21.
23. Kun LE, MacDonald S, Tarbell NJ. Supratentorial Brain Tumors
In: Halperin EC, Constine LS, Tarbell NJ, Kun LE, editors.In:
Pediatric Radiation Oncology, 5th ed. Philadelphia, PA: Lippincott
Williams &Wilkins. 2010:40-3.
24. Ater JL, Zhou T, Holmes E, Mazewski CM, Booth TN, Freyer DR,
Lazarus KH, Packer RJ, Prados M, Sposto R, Vezina G, Wisoff JH,
Pollack IF. Randomized study of two chemotherapy regimens for
treatment of low-grade glioma in young children: a report from the
Children’s Oncology Group.
J Clin Oncol.
2012;30(21):2641-7.
25. Gnekow AK, Kortmann RD, Pietsch T, Emser A. Low grade chias-
matic-hypothalamic glioma-carboplatin and vincristin chemothera-
py effectively defers radiotherapy within a comprehensive treatment
strategy -- report from the multicenter treatment study for children
and adolescents with a low grade glioma -- HIT-LGG 1996 -- of
the Society of Pediatric Oncology and Hematology (GPOH).
Klin
Padiatr.
2004;216(6):331-42.
26. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD,
Gandola L, Riva D, Ruggiero A, Valentini L, Mazza E, Genitori
L, Di Rocco C, Navarria P, Casanova M, Ferrari A, Luksch R,
Terenziani M, Balestrini MR, Colosimo C, Fossati-Bellani F. High
response rate to cisplatin/etoposide regimen in childhood low-grade
glioma.
J Clin Oncol.
2002;20(20):4209-16.
27. Bandopadhayay P, Bergthold G, London WB, Goumnerova LC,
Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison
NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE. Long-term
outcome of 4,040 children diagnosed with pediatric low-grade glio-
mas: an analysis of the Surveillance Epidemiology and End Results
(SEER) database.
Pediatr Blood Cancer.
2014;61(7):1173-9.
28. Williams N, Rotondo R, Bradley J, Pincus D, Fort J, Morris C,
Mendenhall N, Marcus R, Indelicato D. Late Effects Following
Radiation Therapy for Childhood Low-Grade Glioma.
Int J Radiat
Oncol Biol Phys.
2013;87(2):S594.
29. Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke
U. Proton versus photon radiotherapy for common pediatric
brain tumors: comparison of models of dose characteristics
and their relationship to cognitive function.
Pediatr Blood
Cancer.
2008;51(1):110-7.
30. Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C,
Xiong X, Boop FA, Sanford RA. Phase II trial of conformal
radiation therapy for pediatric patients with craniopharyngio-
ma and correlation of surgical factors and radiation dosimetry
with change in cognitive function.
J Neurosurg.
2006;104(2
Suppl):94-102.
31. Merchant TE, Conklin H, Onar-Thomas A, Boop F. Lon-
gitudinal Models of Cognitive Function in Children With
Craniopharyngioma Demonstrate the Effect of Radiation
Dose.
Int J Radiat Oncol Biol Phys.
2013;87:S38-S9.
32. Shaw E, Arusell R, Scheithauer B, O’Fallon J, O’Neill B,
Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols
D, Ivnik R, Hellman R, Curran W, Abrams R. Prospective
randomized trial of low- versus high-dose radiation therapy in
adults with supratentorial low-grade glioma: initial report of
a North Central Cancer Treatment Group/Radiation Therapy
Oncology Group/Eastern Cooperative Oncology Group
study.
J Clin Oncol.
2002;20(9):2267-76.
33. Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright
KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A.
Necrosis after craniospinal irradiation: results from a prospec-
tive series of children with central nervous system embryonal
tumors.
Int J Radiat Oncol Biol Phys.
2012;83(5):e655-60.
34. Merchant TE, Chitti RM, Li C, Xiong X, Sanford RA, Khan
RB. Factors associated with neurological recovery of brainstem
function following postoperative conformal radiation therapy
for infratentorial ependymoma.
Int J Radiat Oncol Biol Phys.
2010;76(2):496-503.
35. Christopherson KM, Rotondo RL, Bradley JA, Pincus DW,
Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus
RB, Jr., Indelicato DJ. Late toxicity following craniospi-
nal radiation for early-stage medulloblastoma.
Acta Oncol.
2014;53(4):471-80.
36. Friedman DL, Whitton J, Leisenring W, Mertens AC, Ham-
mond S, Stovall M, Donaldson SS, Meadows AT, Robison
LL, Neglia JP. Subsequent neoplasms in 5-year survivors of
childhood cancer: the Childhood Cancer Survivor Study.
J
Natl Cancer Inst.
2010;102(14):1083-95.
37. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduc-
tion of the incidence of radiation-induced second cancers by
using proton beams in the treatment of pediatric tumors.
Int J
Radiat Oncol Biol Phys.
2002;54(3):824-9.
38. Chang AL, Yock TI, Mahajan A, Hill-Kaiser C, Keole S, Lore-
do L, Cahlon O, McMullen KP, Hartsell WF, Indelicato DJ.
Pediatric Proton Therapy: Patterns of Care across the United
States.
Int J Particle Ther.
2014;1(2):357-67.
